# COVID Card Pilot Study to Detect Antibodies to SARS-CoV-2

> **NCT05196932** · — · COMPLETED · sponsor: **University of Maryland, Baltimore** · enrollment: 56 (actual)

## Conditions studied

- COVID-19
- SARS-CoV2 Infection

## Interventions

- **DEVICE:** Novel point-of-care, semi-quantitative test for SARS-CoV-2 antibodies

## Key facts

- **NCT ID:** NCT05196932
- **Lead sponsor:** University of Maryland, Baltimore
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-08-31
- **Primary completion:** 2023-04-21
- **Final completion:** 2023-04-21
- **Target enrollment:** 56 (ACTUAL)
- **Last updated:** 2023-05-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05196932

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05196932, "COVID Card Pilot Study to Detect Antibodies to SARS-CoV-2". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT05196932. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*